Carl Van Ness
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- Berberine and alkaloids research
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
- Cytokine Signaling Pathways and Interactions 1
-
- Peroxisome Proliferator-Activated Receptors 1
- PI3K/AKT/mTOR signaling in cancer 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Wendong Huang (6 shared papers)Xiaoxiao Ma (4 shared papers)Zhipeng Meng (5 shared papers)Xianghui Fu (3 shared papers)Guiyu Lou (3 shared papers)Rongzhen Xu (3 shared papers)Xiaoqiong Wang (4 shared papers)Yichao Gan (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Leukemia (1 paper)Journal of Hepatology (1 paper)Oncogene (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Carl Van Ness
6 papers receiving 336 citations
Peers
Comparison fields: 5 of 57
- Oncology 114
- Pharmacology 27
- Molecular Biology 208
- Cancer Research 39
- Hepatology 19
Countries citing papers authored by Carl Van Ness
This map shows the geographic impact of Carl Van Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Van Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Van Ness more than expected).
Fields of papers citing papers by Carl Van Ness
This network shows the impact of papers produced by Carl Van Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Van Ness. The network helps show where Carl Van Ness may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Van Ness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 92 | |
| 2 | 2013 | 72 | |
| 3 | 2012 | 71 | |
| 4 | 2014 | 70 | |
| 5 | 2012 | 25 | |
| 6 | 2016 | 13 |
About Carl Van Ness
Carl Van Ness is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Pharmacology, having authored 6 papers that have together received 343 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Liver Disease Diagnosis and Treatment (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Pediatric Hepatobiliary Diseases and Treatments (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cholesterol and Lipid Metabolism (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (114 citations), Pharmacology (27 citations), Molecular Biology (208 citations), Cancer Research (39 citations) and Hepatology (19 citations). Carl Van Ness has collaborated with scholars based in United States and China. Frequent co-authors include Wendong Huang, Xiaoxiao Ma, Zhipeng Meng, Xianghui Fu, Guiyu Lou, Rongzhen Xu, Xiaoqiong Wang, Yichao Gan, Xichun Wang and Donna Yu. Their work appears in journals such as Molecular Cancer Therapeutics, Leukemia, Journal of Hepatology, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.